Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01742338 · ClinicalTrials.gov registry record · Phase 4
Dose of Corticosteroids in COPD
A Phase 4 study, sponsored by Rutgers, The State University of New Jersey.
- Terminated
- Registry status
- Phase 4
- Development phase
- 89
- Enrollment target
NCT01742338 is a Phase 4 study that was terminated before completion, run by Rutgers, The State University of New Jersey. The registered enrollment target is 89 participants.
The verdict
NCT01742338, a Phase 4 study, was terminated before completion, sponsored by Rutgers, The State University of New Jersey.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 89 participants
- Enrollment target
Study Summary
COPD (chronic obstructive pulmonary disease) is a long-lasting lung disease usually caused by long-term smoking. COPD can get worse, making people sick enough to need hospitalization. Corticosteroids are very effective and are almost always used, but nobody knows the right dose. High doses may work better but could cause more side effects than low doses. Typical treatment lengths last at least one week. This study will be comparing two common regimens: either 40mg of corticosteroids daily (low dose), or 80mg of corticosteroids daily (high dose). It is unknown which regimen works better..
Interventions
- DRUG Low Dose Corticosteroids
- DRUG High Dose Corticosteroids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2012-05-03 |
| Est. Completion | 2020-03-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01742338
The ClinicalTrials.gov registry entry for NCT01742338 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Low Dose Corticosteroids is the first listed.
NCT01742338 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01742338 about?
NCT01742338 is a clinical study titled "Dose of Corticosteroids in COPD". COPD (chronic obstructive pulmonary disease) is a long-lasting lung disease usually caused by long-term smoking. COPD can get worse, making people sick enough to need hospitalization. Corticosteroids are very effective and are almost always used, but nobody knows the right dose. High doses may work ...
What is the current status of trial NCT01742338?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 89 participants. The study started on 2012-05-03. Estimated completion is 2020-03-15.
What interventions are being tested in trial NCT01742338?
The interventions under investigation include: Low Dose Corticosteroids (DRUG), High Dose Corticosteroids (DRUG).
Who is sponsoring clinical trial NCT01742338?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.